Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: March 2012

Chapter 79 - Cavernous malformations

from Section 3 - Symptomatic epilepsy

Summary

The frequency of epilepsy in certain conditions is well known, for example, de novo epilepsy after operative treatment of intracranial abscess is around 70% but this would probably occur independent of the surgical technique used. It seems that craniotomy probably increases the liability of de novo epilepsy by 5-10%. The complexity of the procedure also increases the incidence. Studies of post-traumatic epilepsy with modern imaging techniques have shown the relationship between cortical damage, in particular cortical contusions and post-traumatic epilepsy. The literature on cerebral tumors suggests that late postoperative seizures are more likely to be partial seizures and may be more difficult to control. Antiepileptic drugs (AEDs) are known to be metabolized along established pathways that they may share with other AEDs and also with non-anticonvulsant drugs. Other treatments such as further surgery and adjuvant therapy for intracranial tumors may be useful in treating difficult de novo seizures.

References

Baumann CR, Schuknecht B, Lo Russo G, et al. (2006) Seizure outcome following resection of cavernous malformations is better when surrounding hemosiderin-stained brain is also removed. Epilepsia 47:563–6.
Baumann CR, Acciarri N, Bertalanffy H, et al. (2007) Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48:559–63.
Bergametti F, Denier C, Labauge P, et al. (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76:42–51.
Bertalanffy H, Benes L, Miyazawa T, et al. (2002) Cerebral cavernomas in the adult: review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev 25:1–53.
Bremer L, Carson NB (1890) A case of brain tumor (angioma cavernosum), causing spastic paralysis and attacks of tonic spasms: operation. Am J Med Sci 100:219–42.
Casazza M, Broggi G, Franzini A, et al. (1996) Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery 39:26–32.
Chang EF, Gabriel RA, Potts MB, et al. (2009) Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery 65:31–7.
Del Curling O Jr., Kelly DL, Elster AD, Craven TE (1991) An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702–8.
Detwiler PW, Porter RW, Zabramski JM, Spetzler RF (1997) De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage – case report and review of the literature. J Neurosurg 87:629–32.
Folkersma H, Mooij JJ (2001) Follow-up of 13 patients with surgical treatment of cerebral cavernous malformations: effect on epilepsy and patient disability. Clin Neurol Neurosurg 103:67–71.
Kondziolka D, Lunsford LD, Kestle JR (1995) The natural history of cerebral cavernous malformations. J Neurosurg 83:820–4.
Kraemer DL, Awad IA (1994) Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia 35:S30–43.
Kufs H (1928) Über die heredofamiläre Angiomatose des Gehirns und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Neurol Psychiatrie 113:651–86.
Laberge-le Couteulx S, Jung HH, Labauge P, et al. (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189–93.
Liquori CL, Berg MJ, Siegel AM, et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459–64.
Luschka H (1854) Cavernöse Blutgeschwulst des Gehirnes. Virchows Archiv pathol Anat 6:458–70.
Maraire JN, Awad IA (1995) Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery 37:591–605.
McCormick WF, Hardman JM, Boulter TR (1968) Vascular malformations (angiomas) of the brain, with special reference to those occurring in the posterior fossa. J Neurosurg 28:241–51.
Moran NF, Fish DR, Kitchen N, et al. (1999) Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 66:561–8.
Ohlmacher AP (1899) Multiple cavernous angioma, fibroendothelioma, osteoma and hematomyelia of the central nervous system in a case of secondary epilepsy. J Nerv Ment Dis 26:395–412.
Otten P, Pizzolato GP, Rilliet B, Berney J (1989) A propos de 131 cas d'angiomas caverneux (cavernomas) du S.N.C, repérés par l'analyse retrospective de 24535 autopsies. Neurochirurgie (Paris) 35:82–3.
Porter PJ, Willinsky RA, Harper W, Wallace MC (1997) Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 87:190–7.
Robinson JR, Awad IA, Little JR (1991) Natural history of the cavernous angioma. J Neurosurg 75:709–14.
Russel DS, Rubinstein LJ (1989) Pathology of Tumors of the Nervous System, 5th edn. Baltimore, MD: Williams and Wilkins, pp.727–90.
Sarwar M, McCormick WF (1978) Intracerebral venous angioma: case report and review. Arch Neurol 35:323–5.
Simard JM, Garcia-Bengochea F, Ballinger WE, Jr., Mickle JP, Quisling RG (1986) Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 18:162–72.
Stefan H, Hammen T (2004) Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 110:393–7.
Yaşargil MG (1987) Microneurosurgery, vols. IIIA and B. Stuttgart, Germany: Thieme.
Zabramski JM, Wascher TM, Spetzler RF, et al. (1994) The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 80:422–32.